| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $8.97M | - | |
| VP | 80.0K | $4.50M | - | |
| VP | 55.1K | $3.10M | - | |
| Dir | 49.4K | $2.78M | - | |
| Dir | 46.4K | $2.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2018 | Lewis Alan | Director | Sell | 4,200 | $100.09 | $420,365.40 | -16.6% | |
| Aug 7, 2018 | Baffi Robert | EVP, Technical Operations | Sell | 5,173 | $105.00 | $543,165.00 | -6.7% | |
| Aug 7, 2018 | Mueller Brian64 | SVP, Corporate Controller | Sale+OE | 2,500 | $104.50 | $261,250.00 | -16.8% | |
| Jul 23, 2018 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 1,500 | $101.69 | $152,535.00 | -0.5% | |
| Jun 27, 2018 | Lawlis V Bryan53 | Director | Sale+OE | 2,150 | $93.52 | $201,068.00 | -10.1% | |
| Jun 22, 2018 | Mueller Brian64 | SVP, Corporate Controller | Sale+OE | 3,145 | $99.50 | $312,927.50 | -11.3% | |
| Jun 22, 2018 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sell | 10,000 | $99.00 | $990,004.72 | -8.9% | |
| Jun 22, 2018 | Baffi Robert | EVP, Technical Operations | Sale+OE | 6,949 | $99.00 | $687,954.28 | -4.0% | |
| Jun 15, 2018 | Mueller Brian64 | SVP, Corporate Controller | Sell | 2,021 | $94.50 | $190,984.50 | -13.4% | |
| Jun 14, 2018 | Fuchs Henry J | President, Worldwide R&D | Sale+OE | 31,000 | $90.00 | $2,790,084.79 | -3.8% |